Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics-Reference-Cited by-同舟云学术

Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics

Published:2020-12-29 Issue:3 Volume:17 Page:307-321
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Slanař Ondřej¹,Hronová Karolína¹,Bartošová Olga¹,Šíma Martin¹^ORCID

Affiliation:

1. Department of Pharmacology, Charles University and General University Hospital, Prague, Czech Republic

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2021.1865310

Reference159 articles.

1. Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen

2. Breast Cancer: Current Perspectives on the Disease Status

3. WHO: Cancer [Internet]. World Health Organization; 2020 [cited 2020 Oct 02]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer

4. Wormann B. Breast cancer: basics, screening, diagnostics and treatment. Med Monatsschr Pharm. 2017 Feb;40(2):55–64.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tamoxifen Activates Transcription Factor EB and Triggers Protective Autophagy in Breast Cancer Cells by Inducing Lysosomal Calcium Release: A Gateway to the Onset of Endocrine Resistance;International Journal of Molecular Sciences;2023-12-29

2. Etiology and Therapy of Hormone Receptor‐Positive Breast Cancer;Drug and Therapy Development for Triple Negative Breast Cancer;2023-06-16

3. Aspirin and Risk of Specific Breast Cancer Subtype in Women with Diabetes;Journal of Women's Health;2023-03-01

4. Circular RNA circMET contributes to tamoxifen resistance of breast cancer cells by targeting miR-204/AHR signaling;Biochemical and Biophysical Research Communications;2022-10

5. Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial;Breast Cancer Research and Treatment;2022-07-16